Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer-Reference-Cited by-同舟云学术

Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer

Published:2024-06-11 Issue:8 Volume:25 Page:181-192
ISSN:1527-2737
Container-title:Current Urology Reports
language:en
Short-container-title:Curr Urol Rep

Author:

Mattes Malcolm D.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11934-024-01217-5.pdf

Reference148 articles.

1. National Comprehensive Cancer Network. NCCN Guidelines, Prostate Cancer. 2023. p. NCCN Guidelines Version 4.2023. Available from https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459.

2. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;43(5):1095–101. https://doi.org/10.1016/s0360-3016(98)00438-6.

3. Pollack A, Walker G, Horwitz EM, Price R, Feigenberg S, Konski AA, et al. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol. 2013;31(31):3860–8. https://doi.org/10.1200/JCO.2013.51.1972.

4. Lee WR, Dignam JJ, Amin MB, Bruner DW, Low D, Swanson GP, et al. Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer. J Clin Oncol. 2016;34(20):2325–32. https://doi.org/10.1200/JCO.2016.67.0448.

5. Dearnaley D, Syndikus I, Sumo G, Bidmead M, Bloomfield D, Clark C, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol. 2012;13(1):43–54. https://doi.org/10.1016/S1470-2045(11)70293-5.